Your browser doesn't support javascript.
loading
Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis.
Chiang, Cho-Han; Chiang, Cho-Hung; Pickering, John W; Stoyanov, Kiril M; Chew, Derek P; Neumann, Johannes T; Ojeda, Francisco; Sörensen, Nils A; Su, Ke-Ying; Kavsak, Peter; Worster, Andrew; Inoue, Kenji; Johannessen, Tonje R; Atar, Dan; Amann, Michael; Hochholzer, Willibald; Mokhtari, Arash; Ekelund, Ulf; Twerenbold, Raphael; Mueller, Christian; Bahrmann, Philipp; Buttinger, Nicolas; Dooley, Maureen; Ruangsomboon, Onlak; Nowak, Richard M; DeFilippi, Christopher R; Peacock, William F; Neilan, Tomas G; Liu, Michael A; Hsu, Wan-Ting; Lee, Gin Hoong; Tang, Pui-Un; Ma, Kevin Sheng-Kai; Westermann, Dirk; Blankenberg, Stefan; Giannitsis, Evangelos; Than, Martin P; Lee, Chien-Chang.
Afiliação
  • Chiang CH; Harvard Medical School, Boston, Massachusetts, and National Taiwan University College of Medicine, Taipei, Taiwan (Cho-Han Chiang).
  • Chiang CH; Taipei Tzu Chi Hospital, Buddhist Tzu Chi Foundation, New Taipei City, Taiwan (Cho-Hung Chiang).
  • Pickering JW; Christchurch Hospital and University of Otago Christchurch, Christchurch, New Zealand (J.W.P.).
  • Stoyanov KM; University Hospital of Heidelberg, Heidelberg, Germany (K.M.S., E.G.).
  • Chew DP; Flinders University of South Australia, Adelaide, Australia (D.P.C.).
  • Neumann JT; Monash University, Melbourne, Australia, and University Heart & Vascular Center Hamburg, Hamburg, Germany (J.T.N.).
  • Ojeda F; University Heart & Vascular Center Hamburg, Hamburg, Germany (F.O., N.A.S., D.W., S.B.).
  • Sörensen NA; University Heart & Vascular Center Hamburg, Hamburg, Germany (F.O., N.A.S., D.W., S.B.).
  • Su KY; National Taiwan University Hospital, Taipei, Taiwan (K.S., G.H.L., P.T.).
  • Kavsak P; McMaster University, Hamilton, Ontario, Canada (P.K., A.W.).
  • Worster A; McMaster University, Hamilton, Ontario, Canada (P.K., A.W.).
  • Inoue K; Juntendo University Nerima Hospital, Tokyo, Japan (K.I.).
  • Johannessen TR; University of Oslo and Oslo Accident and Emergency Outpatient Clinic, Oslo, Norway (T.R.J.).
  • Atar D; Oslo University Hospital, Ullevaal, and University of Oslo, Oslo, Norway (D.A.).
  • Amann M; University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany (M.A., W.H.).
  • Hochholzer W; University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany (M.A., W.H.).
  • Mokhtari A; Skåne University Hospital, Lund University, Lund, Sweden (A.M., U.E.).
  • Ekelund U; Skåne University Hospital, Lund University, Lund, Sweden (A.M., U.E.).
  • Twerenbold R; University of Basel, Basel, Switzerland, University Heart and Vascular Center Hamburg, Hamburg, Germany, and German Center for Cardiovascular Research (DZHK) Partner Site Hamburg-Kiel-Lübeck (R.T.).
  • Mueller C; University of Basel, Basel, Switzerland (C.M.).
  • Bahrmann P; Friedrich-Alexander-University Erlangen-Nuremberg, Nuremberg, Germany (P.B.).
  • Buttinger N; Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom (N.B., M.D.).
  • Dooley M; Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom (N.B., M.D.).
  • Ruangsomboon O; Siriraj Hospital, Mahidol University, Bangkok, Thailand (O.R.).
  • Nowak RM; Henry Ford Health System, Detroit, Michigan (R.M.N.).
  • DeFilippi CR; Inova Heart and Vascular Institute, Falls Church, Virginia (C.R.D.).
  • Peacock WF; Baylor College of Medicine, Houston, Texas (W.F.P.).
  • Neilan TG; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, Massachusetts (T.G.N.).
  • Liu MA; Warren Alpert Medical School of Brown University, Providence, Rhode Island (M.A.L.).
  • Hsu WT; Harvard School of Public Health, Boston, Massachusetts (W.H.).
  • Lee GH; National Taiwan University Hospital, Taipei, Taiwan (K.S., G.H.L., P.T.).
  • Tang PU; National Taiwan University Hospital, Taipei, Taiwan (K.S., G.H.L., P.T.).
  • Ma KS; Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, and National Taiwan University, Taipei, Taiwan (K.S.M.).
  • Westermann D; University Heart & Vascular Center Hamburg, Hamburg, Germany (F.O., N.A.S., D.W., S.B.).
  • Blankenberg S; University Heart & Vascular Center Hamburg, Hamburg, Germany (F.O., N.A.S., D.W., S.B.).
  • Giannitsis E; University Hospital of Heidelberg, Heidelberg, Germany (K.M.S., E.G.).
  • Than MP; Christchurch Hospital and Christchurch Heart Institute, University of Otago Christchurch, Christchurch, New Zealand (M.P.T.).
  • Lee CC; The Centre for Intelligent Healthcare, National Taiwan University Hospital, Taipei, Taiwan (C.L.).
Ann Intern Med ; 175(1): 101-113, 2022 01.
Article em En | MEDLINE | ID: mdl-34807719
BACKGROUND: The 2020 European Society of Cardiology (ESC) guidelines recommend using the 0/1-hour and 0/2-hour algorithms over the 0/3-hour algorithm as the first and second choices of high-sensitivity cardiac troponin (hs-cTn)-based strategies for triage of patients with suspected acute myocardial infarction (AMI). PURPOSE: To evaluate the diagnostic accuracies of the ESC 0/1-hour, 0/2-hour, and 0/3-hour algorithms. DATA SOURCES: PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and Scopus from 1 January 2011 to 31 December 2020. (PROSPERO: CRD42020216479). STUDY SELECTION: Prospective studies that evaluated the ESC 0/1-hour, 0/2-hour, or 0/3-hour algorithms in adult patients presenting with suspected AMI. DATA EXTRACTION: The primary outcome was index AMI. Twenty unique cohorts were identified. Primary data were obtained from investigators of 16 cohorts and aggregate data were extracted from 4 cohorts. Two independent authors assessed each study for methodological quality. DATA SYNTHESIS: A total of 32 studies (20 cohorts) with 30 066 patients were analyzed. The 0/1-hour algorithm had a pooled sensitivity of 99.1% (95% CI, 98.5% to 99.5%) and negative predictive value (NPV) of 99.8% (CI, 99.6% to 99.9%) for ruling out AMI. The 0/2-hour algorithm had a pooled sensitivity of 98.6% (CI, 97.2% to 99.3%) and NPV of 99.6% (CI, 99.4% to 99.8%). The 0/3-hour algorithm had a pooled sensitivity of 93.7% (CI, 87.4% to 97.0%) and NPV of 98.7% (CI, 97.7% to 99.3%). Sensitivity of the 0/3-hour algorithm was attenuated in studies that did not use clinical criteria (GRACE score <140 and pain-free) compared with studies that used clinical criteria (90.2% [CI, 82.9 to 94.6] vs. 98.4% [CI, 88.6 to 99.8]). All 3 algorithms had similar specificities and positive predictive values for ruling in AMI, but heterogeneity across studies was substantial. Diagnostic performance was similar across the hs-cTnT (Elecsys; Roche), hs-cTnI (Architect; Abbott), and hs-cTnI (Centaur/Atellica; Siemens) assays. LIMITATION: Diagnostic accuracy, inclusion and exclusion criteria, and cardiac troponin sampling time varied among studies. CONCLUSION: The ESC 0/1-hour and 0/2-hour algorithms have higher sensitivities and NPVs than the 0/3-hour algorithm for index AMI. PRIMARY FUNDING SOURCE: National Taiwan University Hospital.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Troponina / Algoritmos / Biomarcadores / Triagem / Guias de Prática Clínica como Assunto / Infarto do Miocárdio Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Ann Intern Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Troponina / Algoritmos / Biomarcadores / Triagem / Guias de Prática Clínica como Assunto / Infarto do Miocárdio Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Ann Intern Med Ano de publicação: 2022 Tipo de documento: Article